ÂÜÀòÂÒÂ×

Carlos Gomez-Roca, MD, PhDs is an experienced Head of the Early Phase Unit at INSTITUT CLAUDIUS REGAUD, specializing in bringing new treatments to patients through drug development. Carlos is also a Medecin Specialiste de CLCC at the same company and a member of the ESMO Faculty - MCBS Extended Work Group at ESMO, focusing on evaluating the impact of new drugs on cancer patients. Prior to this, Carlos worked at Institut Gustave Roussy, with a focus on drug development for gastrointestinal tumors and lung cancer. Carlos holds multiple degrees in medical oncology, immunology, cancer, and internal medicine from various universities.